GURU.Markets stock price, segment price, and overall market index valuation
The company's share price LakeShore Biopharma Co.
The share price of YS Biopharma, a Chinese biopharmaceutical company, depends on the success of its vaccine development and commercialization. The chart reflects both the potential of the vast Chinese market and the regulatory risks and intense competition.
Share prices of companies in the market segment - Pharma infections
Y-mAbs Therapeutics (formerly LakeShore Biopharma) is a biopharmaceutical company developing antibody-based therapies for the treatment of childhood cancers. We have classified it in the Pharma: Infections category. The chart below shows how the market values companies fighting rare cancers.
Broad Market Index - GURU.Markets
LSB Industries is a producer of nitrogen chemicals for agriculture and industry. As a component of the GURU.Markets index, its shares are closely linked to natural gas prices and the state of the agricultural sector. The chart below represents the entire market. See how this company's shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
LSB - Daily change in the company's share price LakeShore Biopharma Co.
LakeShore Biopharma Co.'s daily share price fluctuations reflect the high volatility inherent in biotech companies. This metric measures the company's sensitivity to news about the clinical trials of its vaccines and therapeutics.
Daily change in the price of a set of shares in a market segment - Pharma infections
LakeShore Biopharma Co. is a biotech company. This chart highlights the extreme volatility of the sector. Comparing it to LSB's performance, which is dependent on clinical trial results, helps assess its riskiness compared to more diversified companies.
Daily change in the price of a broad market stock, index - GURU.Markets
LakeShore Biopharma is a pharmaceutical company specializing in infectious diseases. Its shares are driven by news about new drug developments. This dynamic, specific to the pharmaceutical industry, creates fluctuations that contribute to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization LakeShore Biopharma Co.
The year-over-year performance of LakeShore Biopharma Co., trading as YS Biopharma, tells the story of its performance in the vaccine market. Its market cap change over the past 12 months reflects its success in selling its rabies vaccine, as well as progress in new product development, which is key to its growth in Asian and other international markets.
Annual dynamics of market capitalization of the market segment - Pharma infections
As an early-stage biotech company, Y-S is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about its vaccine clinical trials. Its stock price will reflect investors' speculative belief in the potential of its unique developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
The ticker symbol LSB belongs to LSB Industries, not LakeShore Biopharma. LSB, a nitrogen fertilizer producer, is a cyclical commodity company. Its stock performance is closely tied to fertilizer prices, which, in turn, depend on natural gas prices and the state of the agricultural sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization LakeShore Biopharma Co.
LakeShore Biopharma is a biopharmaceutical company. Its monthly price performance is typical for the sector: it depends on progress in its scientific developments and clinical programs. News of trial results or funding raises are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Pharma infections
LakeShore Biopharma is likely a biopharmaceutical company focused on infectious diseases. This sector requires constant innovation to combat new and mutating pathogens. The chart below shows how investors assessed the prospects of companies developing vaccines and antiviral drugs.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
LakeShore Biopharma, formerly YS Biopharma, is a biopharmaceutical company developing next-generation vaccines and therapeutics. The company's future depends solely on the success of its clinical trials. The broader market chart serves as a contrasting backdrop to how its scientific breakthroughs and biotech news have given its stock a life of its own.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization LakeShore Biopharma Co.
LakeShore Biopharma is a biopharmaceutical company. Its weekly stock price, like many companies in the sector, is volatile and depends on news about clinical trials, partnerships with other companies, and decisions by regulatory bodies such as the FDA.
Weekly dynamics of market capitalization of the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company. Its weekly stock price, like many companies in the sector, is volatile and dependent on news about clinical trials, partnerships with other companies, and decisions by regulatory bodies such as the FDA.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
LakeShore, a biotech company, lives in a world of its own. Its performance is driven by clinical trial data. A comparison chart with the S&P 500 clearly demonstrates how the stock can rise or fall, completely ignoring the broader market.
Market capitalization of the company, segment and market as a whole
LSB - Market capitalization of the company LakeShore Biopharma Co.
The LakeShore Biopharma (Y-S Biopharma) market capitalization chart tells the story of this Chinese vaccine developer. Its dynamics reflect both the success of bringing products to market and all the risks associated with biotechnology, including clinical trials and regulatory approval.
LSB - Share of the company's market capitalization LakeShore Biopharma Co. within the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company focused on developing vaccines and therapeutics for infectious diseases. Its market capitalization reflects the potential of its scientific platform. The chart below shows the valuation volatility dependent on clinical trial results.
Market capitalization of the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company focused on infectious diseases. The chart below shows the total market capitalization of the infectious diseases pharmaceuticals sector. It provides insight into the market's scale and the importance of developing new vaccines and therapeutics to combat global health threats.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows vaccine development. LakeShore Biopharma is a biopharmaceutical company. Its volatility line will reflect progress in clinical trials and the company's ability to bring new products to market, especially in the face of intense competition following the pandemic.
Book value capitalization of the company, segment and market as a whole
LSB - Book value capitalization of the company LakeShore Biopharma Co.
LakeShore Biopharma's foundation is its scientific platform and manufacturing capabilities for vaccine development, particularly against hepatitis B. This represents both scientific and material capital. The chart shows how the company is building its capital base for conducting clinical trials and commercializing its immunobiological products.
LSB - Share of the company's book capitalization LakeShore Biopharma Co. within the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company developing vaccines and therapeutics. Its assets include R&D centers and manufacturing facilities. The chart shows the company's share of the physical infrastructure required to create its products.
Market segment balance sheet capitalization - Pharma infections
Vaccine development, as the BCap_Ges chart for biotech shows, is a science-intensive industry. LakeShore Biopharma, working in this field, invests in clinical research and manufacturing processes that meet strict standards, making it a capital-intensive business in its niche.
Book value of all companies included in the broad market index - GURU.Markets
LakeShore Biopharma's balance sheet represents the capital and manufacturing capacity for vaccine development and production. Its value reflects the physical and financial foundation that enables the company to create tangible biologics aimed at combating infectious diseases.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - LakeShore Biopharma Co.
LakeShore Biopharma is a biopharmaceutical company. Its market capitalization, like that of all biotech companies, is derived from the expected success of its drugs, not its current assets. The MvsBCap chart will reflect progress in clinical trials and news related to its infectious disease developments.
Market to book capitalization ratio in a market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company developing vaccines. Its value depends on the success of its clinical programs. The chart shows how investors value its scientific platform and pipeline of vaccine candidates.
Market to book capitalization ratio for the market as a whole
LakeShore Biopharma (Y-S Biopharma) develops vaccines and therapeutics. Like other biopharmaceutical companies, its valuation is determined by its research portfolio. Its market value reflects the potential of its developments to combat infectious diseases, not its tangible assets.
Debts of the company, segment and market as a whole
LSB - Company debts LakeShore Biopharma Co.
LakeShore Biopharma, a biopharmaceutical company, uses raised capital to fund its clinical trials, primarily in the areas of vaccines and infectious diseases. Developing and bringing new vaccines to market is an extremely expensive and time-consuming process. This chart shows how the company manages its resources in this capital-intensive endeavor.
Market segment debts - Pharma infections
LakeShore Biopharma is a pharmaceutical company developing vaccines and biologics. Vaccine production is a capital-intensive process, requiring investment in sophisticated manufacturing facilities and lengthy clinical trials. This chart shows how the company funds its research and development in this strategically important area of healthcare.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio LakeShore Biopharma Co.
LakeShore Biopharma, a developer of vaccines and biologics, requires significant investment in research and production. This chart shows its reliance on debt. High debt in the pharmaceutical industry is always a significant risk, which can only be justified by successfully launching a new, effective drug.
Market segment debt to market segment book capitalization - Pharma infections
LakeShore Biopharma is a biopharmaceutical company focused on developing vaccines and therapeutics for infectious diseases. The chart shows the sector's debt load, helping to understand how the company finances its lengthy and expensive clinical programs compared to other vaccine developers.
Debt to book value of all companies in the market
LakeShore Biopharma, formerly YS Biopharma, develops vaccines and therapeutics against infectious diseases. For a biopharmaceutical company, the overall financial market situation, reflected in this chart, is of paramount importance. It determines the availability of capital for clinical trials and the launch of new products.
P/E of the company, segment and market as a whole
P/E - LakeShore Biopharma Co.
This chart of LakeShore Biopharma, a biopharmaceutical company, shows how investors value its infectious disease developments. The values reflect not current revenues, but rather the expected success of its vaccines or therapeutics in clinical trials and their eventual commercial potential.
P/E of the market segment - Pharma infections
This chart shows the average price-to-earnings ratio for the pharmaceutical industry, where LakeShore Biopharma fights infections. This ratio serves as a benchmark for assessing the premium the market is willing to pay for the company's vaccines and treatments compared to other pharmaceutical developments.
P/E of the market as a whole
LakeShore Biopharma is a biopharmaceutical company specializing in the development of vaccines and therapeutics for infectious diseases. Its success depends on clinical trial results and regulatory approval. This chart shows the biotech sentiment. It helps understand how the market views the company's scientific platform and its chances of creating a commercially successful product in a competitive field.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company LakeShore Biopharma Co.
LakeShore Biopharma is a biopharmaceutical company specializing in vaccine development. Its value depends on the success of its clinical programs and its ability to bring new vaccines to market. This chart reflects analysts' forecasts of the commercial potential of its developments in the fight against infectious diseases.
%20P%2FE%20LakeShore%20Biopharma%20Co.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-LakeShore-Biopharma-Co.&v=1772513613007 "Chart of the company's future (projected) P/E LakeShore Biopharma Co.")
Future (projected) P/E of the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company developing vaccines and other therapeutics to combat infectious diseases. This chart displays its future profitability expectations, allowing you to assess how the market perceives its scientific developments and its potential in the global vaccine market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-infections&v=1772513613025 "Future (projected) P/E graph of the market segment - Pharma infections")
Future (projected) P/E of the market as a whole
LakeShore Biopharma is a biopharmaceutical company focused on infectious diseases. Its valuation, like many companies in this sector, depends on success in clinical trials. This chart, which shows investors' overall risk appetite, influences capital availability. During periods of optimism, funding for biotech becomes more accessible.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513613050 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit LakeShore Biopharma Co.
LakeShore Biopharma Co. (LSB) is a biopharmaceutical company developing vaccines and therapeutics for infectious diseases. Its profitability depends on successful clinical trials and regulatory approval. This chart shows the investment phase, where capital is invested in the development of life-saving medical products.
Profit of companies in the market segment - Pharma infections
LakeShore Biopharma (Yisheng Biopharma) is a biopharmaceutical company developing vaccines and therapeutics, primarily for Asian markets. Its portfolio includes a rabies vaccine and oncology drugs. This chart illustrates the overall dynamics of the pharmaceutical industry, where companies focusing on specific geographic markets can succeed.
Overall market profit
LakeShore Biopharma, a biopharmaceutical company, is dependent on the success of its clinical trials. Like the entire sector, it's less concerned with the current economic cycle than with access to long-term financing. This graph, reflecting market sentiment, impacts this access and investors' risk appetite.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company LakeShore Biopharma Co.
LakeShore Biopharma is a biopharmaceutical company focused on developing vaccines and therapeutics to combat infectious diseases. Its future depends on success in clinical trials. This chart reflects analyst expectations regarding the commercial potential of its developments and future profitability.
%20profit%20of%20the%20company%20LakeShore%20Biopharma%20Co.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-LakeShore-Biopharma-Co.&v=1772513613134 "Graph of future (projected) profit of the company LakeShore Biopharma Co.")
Future (predicted) profit of companies in the market segment - Pharma infections
LakeShore Biopharma (formerly YS Biopharma) is a biopharmaceutical company specializing in the development of vaccines and therapeutics for the treatment of infectious diseases and cancer. The company uses its proprietary PIKA technology platform. This chart shows profitability projections for the biotech sector, providing context for assessing the potential of its innovative developments.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-infections&v=1772513613165 "Graph of future (predicted) profits of companies in a market segment - Pharma infections")
Future (predicted) profit of the market as a whole
LakeShore Biopharma is a biopharmaceutical company likely focused on developing vaccines or treatments for infectious diseases. Its funding depends on investor interest and government programs. The overall corporate profit forecast, shown in the chart, shapes the investment climate, which influences the availability of capital for such developments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513613193 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - LakeShore Biopharma Co.
LakeShore Biopharma is a biopharmaceutical company. For a development-stage company, this chart shows how much investors believe in its scientific potential. Market value relative to revenue reflects expectations for the future success of its drugs.
P/S market segment - Pharma infections
LakeShore Biopharma Co., Ltd., formerly YS Biopharma, is a biopharmaceutical company focused on vaccine development and commercialization. This chart shows the average revenue estimate in the pharmaceutical sector. It helps understand how investors view the company's vaccine portfolio and its growth potential in the global preventative medicines market.
P/S of the market as a whole
LakeShore Biopharma, formerly YS Biopharma, is a biopharmaceutical company focused on developing vaccines and therapeutics for infectious diseases and cancer. Their success depends on clinical data. This chart provides a general revenue metric that can be used to assess how the market values biotech companies with a broad pipeline.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company LakeShore Biopharma Co.
LakeShore Biopharma (formerly YS Biopharma) is a biopharmaceutical company focused on vaccine development and commercialization. This chart reflects investor expectations for its product portfolio. The valuation depends on the market success of its vaccines, particularly in Asia, and progress in developing new vaccine candidates.
%20P%2FS%20LakeShore%20Biopharma%20Co.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-LakeShore-Biopharma-Co.&v=1772513613372 "The graph of the company's future (projected) P/S LakeShore Biopharma Co.")
Future (projected) P/S of the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company developing vaccines and therapeutics for the treatment of infectious diseases. Its success depends on the results of clinical trials. This chart shows how the market values its pipeline compared to the pharmaceutical sector.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20infections&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-infections&v=1772513613402 "Future (projected) P/S market segment graph - Pharma infections")
Future (projected) P/S of the market as a whole
LakeShore Biopharma is a biopharmaceutical company specializing in the development of vaccines against infectious diseases. This chart, reflecting the overall investment climate in the biotech sector, is important for the company. Market optimism facilitates raising the significant funds needed to conduct large-scale clinical trials and bring new vaccines to market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513613434 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales LakeShore Biopharma Co.
LakeShore Biopharma, formerly YS Biopharma, is a biopharmaceutical company focused on developing vaccines and therapeutic antibodies. This chart shows revenue from sales of its vaccines (such as rabies) and partnerships. It reflects the commercial success of its products in Asian markets.
Sales of companies in the market segment - Pharma infections
LakeShore Biopharma Co., Ltd. (operating as YS Biopharma) is a biopharmaceutical company focused on the development and commercialization of next-generation vaccines. Its business is segmented by various infectious disease vaccine development programs. This chart depicts the cash flows associated with one of its key vaccine candidates.
Overall market sales
LakeShore Biopharma Co. is a biopharmaceutical company focused on infectious diseases. Its success depends on the development and commercialization of vaccines and therapeutics. Demand for its products is driven by the epidemiological situation and the needs of healthcare systems worldwide, rather than by general economic cycles.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company LakeShore Biopharma Co.
LakeShore Biopharma is likely a biopharmaceutical company. Its future sales forecast will depend on the stage of development of its drugs. If they are already on the market, it will depend on sales volumes. If they are in development, it will depend on expectations for the success of clinical trials and potential commercial launch, most likely in the field of infectious diseases.
%20sales%20of%20the%20company%20LakeShore%20Biopharma%20Co.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-LakeShore-Biopharma-Co.&v=1772513613497 "Schedule of future (projected) sales of the company LakeShore Biopharma Co.")
Future (projected) sales of companies in the market segment - Pharma infections
LakeShore Biopharma is a biopharmaceutical company developing vaccines and therapeutics for infectious diseases. This chart shows expectations for the entire vaccine sector. It helps assess the demand for new preventative treatments and the level of public and private investment analysts are forecasting in this area.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-infections&v=1772513613510 "Schedule of future (projected) sales of companies in the market segment - Pharma infections")
Future (projected) sales of the market as a whole
LakeShore Biopharma, a biopharmaceutical company developing vaccines, is a leading global health care company. Its funding and future revenues are dependent on the success of clinical trials and government health programs. This sales forecast chart reflects the state of the economy, which impacts public health budgets.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513613533 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality LakeShore Biopharma Co.
LakeShore Biopharma Co. is a biopharmaceutical company specializing in developing vaccines to combat infectious diseases. Being in clinical trials, it has no commercial revenue. This chart shows its current financial position, dominated by research expenses, which are an investment in future products.
Market segment marginality - Pharma infections
LakeShore Biopharma is a biopharmaceutical company focused on developing vaccines and therapeutics for infectious diseases. Operational efficiency in this field is closely tied to managing long and expensive clinical programs. This chart compares how the company manages its resources with its competitors.
Market marginality as a whole
LakeShore Biopharma Co. is a biopharmaceutical company focused on developing vaccines and therapeutics for infectious diseases. Its success depends on clinical trial results and regulatory approval. This chart shows average profitability, but for LSB, value comes from scientific innovation in a critical area of public health.
Employees in the company, segment and market as a whole
Number of employees in the company LakeShore Biopharma Co.
YS Biopharma (formerly LakeShore Biopharma) is a vaccine manufacturer focused on the Asian market. This chart shows its team of scientists, manufacturing specialists, and clinical trial specialists. The growth of this team reflects efforts to develop new vaccines and expand manufacturing capacity.
Share of the company's employees LakeShore Biopharma Co. within the market segment - Pharma infections
LakeShore Biopharma is likely a biopharmaceutical company developing vaccines or drugs to treat infectious diseases. Research in this field requires a large scientific team. This chart shows its human capital contribution to the fight against global health threats.
Number of employees in the market segment - Pharma infections
LakeShore Biopharma, formerly YS Biopharma, develops vaccines and therapeutics against infectious diseases. This chart reflects employment in this sector. The growing number of virologists and immunologists indicates a global need for new, more effective vaccines, especially given the threat of pandemics, which is the company's core business.
Number of employees in the market as a whole
LakeShore Biopharma is a biopharmaceutical company, and its staff consists of highly qualified scientists. This graph reflects the general labor market, but for LakeShore and similar biotech companies, scientific breakthroughs are key, as they attract investment and allow for the expansion of a top-tier team.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company LakeShore Biopharma Co. (LSB)
LakeShore Biopharma Co., Ltd. (YS Biopharma) develops and manufactures vaccines. Pharmaceutical manufacturing is capital-intensive and requires strict quality control. The moderate capitalization per employee in this chart reflects the value of both the vaccine patents themselves and the manufacturing facilities required to produce them.
%20of%20the%20company%20LakeShore%20Biopharma%20Co.%20(LSB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-LakeShore-Biopharma-Co.-LSB&v=1772513613746 "Chart of market capitalization per employee (in thousands of dollars) of the company LakeShore Biopharma Co. (LSB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma infections
LakeShore Biopharma Co. likely works on biopharmaceuticals, such as vaccines. In this industry, market value per employee is an investor's assessment of the company's scientific potential, manufacturing capacity, and product portfolio. This allows for comparison with other players in the vaccine and biopharmaceutical market.
%20by%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-infections&v=1772513613803 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma infections")
Market capitalization per employee (in thousands of dollars) for the overall market
LakeShore Biopharma Co. (LSB) is a pharmaceutical company focused on developing vaccines and biologics. Vaccine development is a complex and capital-intensive process. The chart shows how the market views the company's scientific potential and manufacturing capabilities.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513613838 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company LakeShore Biopharma Co. (LSB)
LakeShore Biopharma (LSB/YS Biopharma) is a biopharmaceutical company specializing in the development and production of vaccines, particularly against rabies and hepatitis B, with a focus on the Asian market. This chart shows how efficiently their manufacturing facilities and commercial team can produce and market these life-saving vaccines, generating profit per employee.
%20Chart%20LakeShore%20Biopharma%20Co.%20(LSB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-LakeShore-Biopharma-Co.-LSB&v=1772513613863 "Company Profit Per Employee (in thousands of dollars) Chart LakeShore Biopharma Co. (LSB)")
Profit per employee (in thousands of dollars) in the market segment - Pharma infections
LakeShore Biopharma, formerly YS Biopharma, is a biopharmaceutical company developing vaccines and therapeutic antibodies. In this sector, the efficiency of R&D and manufacturing processes is critical. This chart shows how much revenue each employee generates, allowing us to compare their operating model to other pharmaceutical companies.
%20in%20the%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-infections&v=1772513613880 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma infections")
Profit per employee (in thousands of dollars) for the market as a whole
LakeShore Biopharma (LSB) is a biotech company developing vaccines. Vaccine development is a long and expensive process. The company is in the clinical stage. Negative profit per employee is the norm. The chart shows the "cost" of the scientific team conducting trials of a potential blockbuster.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513613886 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee LakeShore Biopharma Co. (LSB)
LakeShore Biopharma is a biopharmaceutical company. Being in the development stage, it may not have stable revenue. This chart will show the future commercial potential of its product portfolio and the effectiveness of its business model.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-LakeShore-Biopharma-Co.-LSB&v=1772513613894 "Sales chart per company employee LakeShore Biopharma Co. (LSB)")
Sales per employee in the market segment - Pharma infections
LakeShore Biopharma (Yisheng) is a biopharmaceutical company developing vaccines (including a rabies vaccine) and immuno-oncology drugs. This chart compares LSB's revenue per employee to the industry average. This demonstrates how productive their R&D and manufacturing platform (if they have sales) are.
Sales per employee for the market as a whole
YS Biopharma (LSB) is a biotech company developing and manufacturing vaccines (such as rabies) for Asian markets. Unlike R&D startups, they have commercial products and manufacturing facilities. This chart shows how effectively their manufacturing facilities and sales team generate revenue from vaccine sales.
Short shares by company, segment and market as a whole
Shares shorted by company LakeShore Biopharma Co. (LSB)
LakeShore Biopharma (LSB) is likely a Chinese biopharmaceutical company developing vaccines or other therapeutics. Chinese biotechs carry dual risks: scientific (the drug could fail) and regulatory (Beijing's policies). This chart shows the number of investors betting against this risky combination.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-LakeShore-Biopharma-Co.-LSB&v=1772513613938 "Short Shares Chart for the Company LakeShore Biopharma Co. (LSB)")
Shares shorted by market segment - Pharma infections
LakeShore Biopharma (LSB) is a Chinese biopharmaceutical company (formerly YS Biopharma) specializing in vaccine development, particularly against rabies and hepatitis B. This chart shows the betting against the vaccine sector, reflecting concerns about intense competition and the difficulty of bringing new vaccines to the global market.
Shares shorted by the overall market
LakeShore Biopharma (Yisheng Bio) is an Asian biotech company developing vaccines. This chart illustrates the overall market pessimism. Investors may be skeptical due to the highly competitive post-COVID vaccine market and geopolitical risks associated with Chinese jurisdiction and funding.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator LakeShore Biopharma Co. (LSB)
LakeShore Biopharma (Yisheng Bio) is a biotech company developing vaccines (including for COVID-19 and rabies) and cancer immunotherapy. This chart tracks market "temperature," showing when the stock is "overheated" (above 70) in anticipation of a breakthrough in trials or "oversold" (below 30) due to delays or setbacks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-LakeShore-Biopharma-Co.-LSB&v=1772513613981 "RSI 14 indicator chart for the company's stock LakeShore Biopharma Co. (LSB)")
RSI 14 Market Segment - Pharma infections
Y-S Biopharma (LSB) is a biopharmaceutical company developing vaccines and therapeutics for infectious diseases and cancer using its PIKA platform. This chart measures the overall momentum of the infectious disease biotech sector. It helps distinguish LSB's performance from the overall hype or decline in the industry.
RSI 14 for the overall market
LakeShore Biopharma (LSB) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast LSB (LakeShore Biopharma Co.)
LSB Industries (LSB) is a major producer of nitrogen fertilizers (ammonia) for agriculture and industrial chemicals used in mining. This chart shows the average target price from analysts, which is directly related to their forecasts for natural gas prices (raw materials) and global fertilizer prices.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-LSB-LakeShore-Biopharma-Co.&v=1772513614096 "A chart showing analyst consensus forecasts for the expected stock price. LSB (LakeShore Biopharma Co.)")
The difference between the consensus estimate and the actual stock price LSB (LakeShore Biopharma Co.)
YS Biopharma (LSB) is a biotech company focused on developing and commercializing vaccines (especially rabies) based on its PIKA platform. This chart measures the gap between the current share price and the consensus target price. It shows the potential experts see in their R&D portfolio and their ability to capture share in the Asian vaccine market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-LSB-LakeShore-Biopharma-Co.&v=1772513614106 "A chart showing the difference between the consensus forecast and the actual stock price. LSB (LakeShore Biopharma Co.)")
Analyst consensus forecast for stock prices by market segment - Pharma infections
YS Biopharma (LSB) is a biotech company developing next-generation vaccines, including those for rabies and hepatitis B. Its success is a bet on R&D. This chart shows analysts' overall expectations for the entire vaccine sector. It reflects whether experts believe new breakthroughs in treating infections are possible or whether they believe the sector is overheated after the pandemic.
Analysts' consensus forecast for the overall market share price
LakeShore Biopharma (LSB) is likely related to YS Biopharma, a company focused on developing next-generation vaccines, particularly for infectious diseases (rabies, hepatitis B). This is a bet on a breakthrough in R&D. This chart shows the overall risk appetite in the market, reflecting the willingness of investors to finance capital-intensive biotech projects.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index LakeShore Biopharma Co.
YS Biopharma (LSB) is a Chinese biotech company specializing in the development and commercialization of vaccines (including their flagship rabies vaccine). This chart is a summary indicator of their growth story. It reflects not only their R&D progress and sales volumes in the competitive Chinese market but also considers the high geopolitical and regulatory risks inherent in this sector.
AKIMA Market Segment Index - Pharma infections
LakeShore Biopharma (LSB), trading as YS Biopharma, is a biopharmaceutical company specializing in the development and commercialization of vaccines against infectious diseases (rabies, hepatitis B). This market requires significant R&D investment. The chart below shows the average value of the composite index for this segment. It allows investors to compare LSB's risks and potential with the overall industry landscape.
The AKIM Index for the overall market
LakeShore Biopharma is a Chinese manufacturer of rabies vaccines and biologics. This chart, showing the average (global/US) market performance, serves as a benchmark. It helps assess how LakeShore Biopharma, operating in China's regulated healthcare market, compares to overall macroeconomic trends.
